370 related articles for article (PubMed ID: 17647026)
1. Mechanisms of progression of chronic kidney disease.
Fogo AB
Pediatr Nephrol; 2007 Dec; 22(12):2011-22. PubMed ID: 17647026
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms in remodeling of the kidney].
Nangaku M; Miyata T
Nihon Rinsho; 2008 Sep; 66(9):1696-700. PubMed ID: 18788396
[TBL] [Abstract][Full Text] [Related]
3. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.
Remuzzi G; Perico N; Macia M; Ruggenenti P
Kidney Int Suppl; 2005 Dec; (99):S57-65. PubMed ID: 16336578
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of Chinese herbal medicine delaying progression of chronic kidney disease].
Dou C; Wan Y; Sun W; Zhagn H; Chen J; Shui G; Yao J
Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(8):939-43. PubMed ID: 19639770
[TBL] [Abstract][Full Text] [Related]
6. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
Picken M; Long J; Williamson GA; Polichnowski AJ
Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
[TBL] [Abstract][Full Text] [Related]
7. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
Ibrahim HN; Rosenberg ME; Hostetter TH
Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
[TBL] [Abstract][Full Text] [Related]
8. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
9. Lipid nephrotoxicity: new concept for an old disease.
Gyebi L; Soltani Z; Reisin E
Curr Hypertens Rep; 2012 Apr; 14(2):177-81. PubMed ID: 22290079
[TBL] [Abstract][Full Text] [Related]
10. Proteinuria: detection and role in native renal disease progression.
Gorriz JL; Martinez-Castelao A
Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
[TBL] [Abstract][Full Text] [Related]
11. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
Ahmed AK; Kamath NS; El Kossi M; El Nahas AM
Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
López-Hernández FJ; López-Novoa JM
Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
[TBL] [Abstract][Full Text] [Related]
13. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?
Ketteler M; Noble NA; Border WA
Annu Rev Physiol; 1995; 57():279-95. PubMed ID: 7778869
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease.
Brown NJ; Vaughan DE; Fogo AB
Semin Nephrol; 2002 Sep; 22(5):399-406. PubMed ID: 12224047
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of kidney fibrosis and the role of antifibrotic therapies.
Deelman L; Sharma K
Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):85-90. PubMed ID: 19077695
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
18. Novel aspects of the renin-angiotensin-aldosterone-system.
Wolf G
Front Biosci; 2008 May; 13():4993-5005. PubMed ID: 18508564
[TBL] [Abstract][Full Text] [Related]
19. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
Rüster C; Wolf G
Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893
[TBL] [Abstract][Full Text] [Related]
20. [Management of chronic kidney disease--preventing the progression of renal disease].
Kuroki A; Akizawa T
Nihon Rinsho; 2008 Sep; 66(9):1735-40. PubMed ID: 18788403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
